Faith, Finances and Caregivers: What Nigeria’s Cancer Survivors Reveal About Guideline Rollout

When cancer treatment ends, the medical journey for many patients does not. Survivors face long-term monitoring, psychological distress, and the difficult task of reintegrating into daily life, needs that fall under the umbrella of cancer survivorship care. In high-income countries, structured survivorship programs have become standard practice since the landmark 2005 National Academies report From Cancer Patient to Cancer Survivor: Lost in Transition. But in much of sub-Saharan Africa, where late diagnosis and limited resources push health systems to prioritize screening, treatment, and palliative care, survivorship has remained largely invisible. A new qualitative study from Nigeria, published in Frontiers in Cancer Control and Society, offers one of the first detailed looks at what it would actually take to change that.

The research, led by Sylvia Shirima of the George Washington University’s Milken Institute School of Public Health, examined barriers and facilitators that could shape the rollout of the National Comprehensive Cancer Network’s harmonized survivorship guidelines for sub-Saharan Africa. Nigeria was a deliberate choice: the country carries the second-highest cancer burden on the continent, and its renewed national cancer control plan now includes a dedicated survivorship pillar. Yet until now, little was known about how patients, caregivers, and providers at the front lines would receive such guidelines, or whether the realities of Nigerian healthcare would allow them to take root.

The team interviewed 22 key informants between September and December 2024 at a major tertiary cancer center in Lagos operating under a public-private partnership. The sample included nine cancer patients, nine healthcare providers, five oncologists, three oncology nurses, and one patient navigator, and four caregivers, most of them spouses of patients. Interviews were conducted over Zoom, lasted roughly 45 minutes each, and continued until thematic saturation was reached by the twentieth interview, with two additional sessions confirming no new themes emerged. Eight of the nine patients were breast cancer survivors, reflecting the profile of the center’s survivor population.

To structure the analysis, the researchers applied the Consolidated Framework for Implementation Research, or CFIR, a widely used determinant framework that organizes contextual factors into domains covering the inner setting of an institution, the outer setting of the surrounding community and policy environment, the characteristics of the intervention itself, and the attributes of the individuals involved. Unlike many studies that invoke CFIR loosely, this team explicitly operationalized its constructs from interview guide design through coding, using deductive codes anchored in the framework alongside inductive codes that captured unexpected insights. A second coder independently reviewed roughly 30 percent of transcripts to ensure reliability.

The findings paint a sobering picture of the cancer care pathway before survivorship even begins. Every patient interviewed reported being unaware of any screening initiative, having either noticed symptoms themselves or sought care for other complaints. Most first encountered the health system at lower-level facilities, where misdiagnosis sometimes delayed referral to the tertiary center. Diagnosis communication varied widely, some patients were told in person, others received results by email or had to collect them actively, an inconsistency the authors flag as warranting attention in any survivorship framework.

Inside the hospital, the barriers were structural. All but one healthcare provider had never heard of the NCCN harmonized survivorship guidelines, a knowledge gap the authors identify as the first obstacle to integration. Providers described chronic shortages of oncology staff and insufficient time per patient, forcing them to prioritize immediate clinical needs over counseling or mental health assessment. Machine breakdowns and maintenance delays compounded the strain. Yet the same interviews revealed genuine assets: patients consistently praised responsive communication with their consultants, including replies to messages outside clinic hours, and providers described a collaborative, participatory culture in which knowledge from conferences and webinars spreads quickly through the team.

When providers evaluated the guideline recommendations themselves, most found them comprehensive, but several noted a disconnect with local realities. Long-term monitoring of treatment effects, one recommendation noted, effectively applies only to patients who can afford to keep returning for follow-up, and those who cannot simply drop out of care. The authors argue that some survivorship services are already being delivered informally, virtual check-ins on chemotherapy side effects, for example, without being recognized or standardized as such. Systematic mapping of existing services, they suggest, could formalize these practices and close the terminology gap.

The outer setting revealed the study’s most striking findings. Financial burden emerged as the dominant barrier across every participant group, with all services at the facility requiring out-of-pocket payment. One patient’s words, quoted in the paper, capture the devastation: This thing turned me to beggar. She described skipping tamoxifen for three months because she could not afford it. Another patient explained how her fabric business capital had been consumed by treatment costs. Providers noted that families often hold meetings to pool money for a relative’s care, and caregivers described being ostracized in their communities as they repeatedly solicited financial help. The authors recommend embedding financial mitigation directly into implementation plans, from formalized charity partnerships to affordable health insurance and even exploring pension fund allocations for cancer care.

Faith and social networks cut both ways. Providers described religious leaders intercepting patients before they reach the hospital, directing them to prayer houses while disease progresses. Family members sometimes vetoed recommended surgeries, with one patient recounting a husband threatening to leave if she underwent a mastectomy. Stigma around mastectomy and chemotherapy side effects added further barriers, with one patient describing pinning folded clothing to simulate a breast for church attendance. Yet faith also served as a profound source of resilience: every patient credited God for their support systems and outcomes, and many drew strength from gospel music, prayer, and positive thinking. The authors argue that rather than ignoring these dynamics, survivorship programs should partner with faith-based organizations to deliver psychosocial support and counter misinformation, and should formally recognize and support caregivers, whose emotional and financial labor is central to patient survival.

The study’s conclusions carry weight beyond Nigeria. The authors propose two care models suited to the setting, a General Survivorship Care Model run through specialist clinics, and a Transition to Primary Care Model that shifts follow-up to lower-level facilities, easing pressure on overburdened oncologists while bringing services closer to communities. They also suggest extending the CFIR framework’s individual characteristics domain to capture attributes of intervention recipients, not just implementers, a refinement with implications for implementation science across low-resource settings. Limitations remain: the single-site design, the predominance of breast cancer patients, and Zoom-based interviews all constrain generalizability. But as Nigeria’s renewed cancer control plan takes shape and other African nations prepare to adopt the harmonized guidelines, this study delivers a clear message: evidence-based recommendations succeed only when they are built around the financial realities, cultural fabric, and human relationships of the communities they aim to serve.

Subject of Research: Implementation of harmonized cancer survivorship guidelines in Nigeria

Article Title: Exploring cancer care pathways and contextual influences on prospective guideline implementation in Nigeria

Article References: Shirima, S., Alabi, A., Onyeka, T., Ndiaye, K., Bamodu, O. A., & Asgary, R. (2026). Exploring cancer care pathways and contextual influences on prospective guideline implementation in Nigeria. Frontiers in Cancer Control and Society, 4, Article 1770216. https://doi.org/10.3389/fcacs.2026.1770216

Image Credits: AI Generated

DOI: 10.3389/fcacs.2026.1770216

Keywords: cancer survivorship, Nigeria, NCCN guidelines, implementation science, CFIR framework, qualitative research, health systems, financial barriers, caregivers, faith and health, sub-Saharan Africa, breast cancer